Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

Videos

Playback speed

10 seconds

2022 State of the Art Frontline Management of the HR-MDS

By Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies FEATURING Rami Komrokji

347 views

February 14, 2022

The partial clinical hold for studies investigating magrolimab in combination with azacitidine in MDS and ...
read more ↘ AML was lifted by FDA on April 11, 2022
↖ read less

Comments 0

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

The First Treatment Choice Matters

Feat. A. Ip

Videos